Status:
RECRUITING
A Study Regarding Tissue Response During and After Treatment for Anal Cancer
Lead Sponsor:
Sahlgrenska University Hospital
Collaborating Sponsors:
Göteborg University
Conditions:
Anal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to improve the understanding for the tumour biology in relation to treatment response in patients with anal cancer by examining: * The tumour microenvironment * The localisat...
Detailed Description
All adult patients with anal cancer presenting within the Sahlgrenska University Hospital catchment area or treated at any time at Sahlgrenska University Hospital are eligible and will be asked to par...
Eligibility Criteria
Inclusion Criteria:
- Newly diagnosed or recurrent anal cancer
Exclusion Criteria:
- No diagnosis of anal cancer, contraindication to biopsies and blood samples
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05939401
Start Date
December 1 2023
End Date
December 1 2029
Last Update
March 18 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, Sweden, SE 416 85
2
Sahlgrenska University Hospital
Gothenburg, Sweden